Getting the flu is more than just uncomfortable—it can actually cause serious health complications (and even death) for older adults or those with pre-existing conditions such as asthma. Despite this,

The FDA has approved the first at-home nasal spray flu vaccine, FluMist, allowing Americans to receive flu protection without visiting a clinic or doctor’s office.

AstraZeneca’s FluMist Home program officially launches today, sending nasal flu vaccines straight to people’s homes. FluMist is a flu vaccine that’s sprayed up your nose. It’s been FDA-approved since 2003, and studies show it works about as well as the traditional flu shot at preventing infections and reducing the risk of serious illness.